KEGG pathway enrichment analysis revealed that key signaling pathways implicated in CHR’s therapeutic effect against SA-AKI include the IL-17, cGMP-PKG, calcium, and NF-κB signaling pathways. This evidence concerns the gene IL17A and acute kidney injury.